rowid,run.accession,experiment.accession,sample.accession,study.accession,bioproject,study.title,study.alias,study.type,study.abstract,study.attributes,study.PMIDs,sample.description,sample.title,sample.alias,sample.centername,sample.attributes,GEOsample.title,GEOsample.dataprocessing,GEOsample.source,GEOsample.treatmentprotocol,GEOsample.extractprotocol,GEOsample.growthprotocol,GEOsample.characteristics,GEOsample.accession,experiment.title,experiment.alias,experiment.library_name,experiment.design_description,experiment.library_construction_protocol,experiment.attributes,experiment.library_strategy,experiment.library_source,experiment.library_selection,experiment.library_layout,experiment.platform,experiment.instrument_model,experiment.spot_descriptor,experiment.study_ref,run.title,run.attributes,run.filename,run.semantic_name,run.total_bases,run.total_spots,run.alias,run.read_lengths,run.base_counts,run.r1_length,run.r2_length,run.r3_length,run.r4_length,run.Acount,run.Ccount,run.Gcount,run.Tcount,run.Ncount,run.experiment,run.pool_member,submission.accession,submission.srasource,submission.bioprojectsource,seqdetective.n_mates,seqdetective.mapping_rate.mate1,seqdetective.mapping_rate.mate2,seqdetective.nofeature_rate.mate1,seqdetective.nofeature_rate.mate2,seqdetective.sparsity.mate1,seqdetective.sparsity.mate2,seqdetective.pos_strand_rate.mate1,seqdetective.pos_strand_rate.mate2,seqdetective.readlen.mate1,seqdetective.readlen.mate2,seqdetective.judgement.mate1,seqdetective.judgement.mate2,seqdetective.judgement.reason,platform_family,instrument_generation,read_bias,selection_class,prep_kit,sc_or_bulk,tech_class,technology,tech_variant,submission.bioprojectsource.country,earliest_date,devstage_curation,devstage_curation_coarse,tissue_curation,tissue_curation_coarse 25308,SRR25793380,SRX21515634,SRS18742881,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes miR 144 embryo,miR 144 embryo,,isolate:miR 144 mutant|age:Embryo|collection date:N/A|geo loc name:N/A|sex:mixed|tissue:Blood|BioSampleModel:Model organism or animal,,,,,,,,,Quant seq Erythrocytes miR 144 mutant Danio rerio 2 dpf replicate 3,144 3 embryo blood,144 3 embryo blood,Libraries were made using QuantSeq three prime mRNA Seq Library Prep Kit for IlluminaLexogen,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina NovaSeq 6000,,SRP457465,,,DC-144EL3_S18.fastq,fastq,687309797.0,17039739.0,DC 144EL3 S18.fastq,0:40.34,A:159186558;C:130452893;G:155820002;T:181676510;N:60173834,40,,,,159186558,130452893,155820002,181676510,60173834,SRX21515634,SRS18742881,SRA1701831,University of East Anglia|Biological Sciences,University of East Anglia,1,0.52966,,0.16941,,0.97615,,0.58418,,61,,B,,usable mapping rate,illumina,novaseq_era,3prime,poly_a,lexogen,bulk,unknown,unknown,,United Kingdom,2023-08-30,Hatching,Embryo,Blood,Hematopoietic System 25309,SRR25793381,SRX21515633,SRS18742881,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes miR 144 embryo,miR 144 embryo,,isolate:miR 144 mutant|age:Embryo|collection date:N/A|geo loc name:N/A|sex:mixed|tissue:Blood|BioSampleModel:Model organism or animal,,,,,,,,,Quant seq Erythrocytes miR 144 mutant Danio rerio 2 dpf replicate 2,144 2 embryo blood,144 2 embryo blood,Libraries were made using QuantSeq three prime mRNA Seq Library Prep Kit for IlluminaLexogen,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina NovaSeq 6000,,SRP457465,,,DC-144EL2_S17.fastq,fastq,495318731.0,14459195.0,DC 144EL2 S17.fastq,0:34.26,A:110392869;C:106378418;G:128881687;T:107956679;N:41709078,34,,,,110392869,106378418,128881687,107956679,41709078,SRX21515633,SRS18742881,SRA1701831,University of East Anglia|Biological Sciences,University of East Anglia,1,0.32147,,0.04496,,0.97569,,0.58512,,31,,B,,usable mapping rate,illumina,novaseq_era,3prime,poly_a,lexogen,bulk,unknown,unknown,,United Kingdom,2023-08-30,Hatching,Embryo,Blood,Hematopoietic System 25310,SRR25793382,SRX21515632,SRS18742881,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes miR 144 embryo,miR 144 embryo,,isolate:miR 144 mutant|age:Embryo|collection date:N/A|geo loc name:N/A|sex:mixed|tissue:Blood|BioSampleModel:Model organism or animal,,,,,,,,,Quant seq Erythrocytes miR 144 mutant Danio rerio 2 dpf replicate 1,144 1 embryo blood,144 1 embryo blood,Libraries were made using QuantSeq three prime mRNA Seq Library Prep Kit for IlluminaLexogen,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina NovaSeq 6000,,SRP457465,,,DC-144EL1_S16.fastq,fastq,974854100.0,20079553.0,DC 144EL1 S16.fastq,0:48.55,A:233861010;C:192987350;G:215192262;T:269960344;N:62853134,48,,,,233861010,192987350,215192262,269960344,62853134,SRX21515632,SRS18742881,SRA1701831,University of East Anglia|Biological Sciences,University of East Anglia,1,0.77953,,0.18084,,0.90905,,0.74157,,75,,B,,usable mapping rate,illumina,novaseq_era,3prime,poly_a,lexogen,bulk,unknown,unknown,,United Kingdom,2023-08-30,Hatching,Embryo,Blood,Hematopoietic System 25311,SRR25793383,SRX21515631,SRS18742879,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes Wild type embryo,WT embryo,,isolate:Wildtype|age:Embryo|collection date:N/A|geo loc name:N/A|sex:mixed|tissue:Blood|BioSampleModel:Model organism or animal,,,,,,,,,Quant seq Erythrocytes Wild type Danio rerio 2 dpf replicate 3,WT3 embryo blood,WT3 embryo blood,Libraries were made using QuantSeq three prime mRNA Seq Library Prep Kit for IlluminaLexogen,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina NovaSeq 6000,,SRP457465,,,DC-WTE3_S15.fastq,fastq,657139116.0,15618072.0,DC WTE3 S15.fastq,0:42.08,A:154495614;C:122942896;G:147719345;T:179403193;N:52578068,42,,,,154495614,122942896,147719345,179403193,52578068,SRX21515631,SRS18742879,SRA1701831,University of East Anglia|Biological Sciences,University of East Anglia,1,0.56358,,0.19381,,0.96757,,0.6115,,76,,B,,usable mapping rate,illumina,novaseq_era,3prime,poly_a,lexogen,bulk,unknown,unknown,,United Kingdom,2023-08-30,Hatching,Embryo,Blood,Hematopoietic System 25314,SRR25793386,SRX21515628,SRS18742879,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes Wild type embryo,WT embryo,,isolate:Wildtype|age:Embryo|collection date:N/A|geo loc name:N/A|sex:mixed|tissue:Blood|BioSampleModel:Model organism or animal,,,,,,,,,Quant seq Erythrocytes Wild type Danio rerio 2 dpf replicate 2,WT2 embryo blood,WT2 embryo blood,Libraries were made using QuantSeq three prime mRNA Seq Library Prep Kit for IlluminaLexogen,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina NovaSeq 6000,,SRP457465,,,DC-WTE2_S14.fastq,fastq,250958009.0,9755304.0,DC WTE2 S14.fastq,0:25.73,A:43225839;C:41823862;G:54150092;T:43159724;N:68598492,25,,,,43225839,41823862,54150092,43159724,68598492,SRX21515628,SRS18742879,SRA1701831,University of East Anglia|Biological Sciences,University of East Anglia,1,0.34114,,0.05466,,0.96664,,0.54625,,47,,B,,usable mapping rate,illumina,novaseq_era,3prime,poly_a,lexogen,bulk,unknown,unknown,,United Kingdom,2023-08-30,Hatching,Embryo,Blood,Hematopoietic System 25315,SRR25793387,SRX21515627,SRS18742879,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes Wild type embryo,WT embryo,,isolate:Wildtype|age:Embryo|collection date:N/A|geo loc name:N/A|sex:mixed|tissue:Blood|BioSampleModel:Model organism or animal,,,,,,,,,Quant seq Erythrocytes Wild type Danio rerio 2 dpf replicate 1,WT1 embryo blood,WT1 embryo blood,Libraries were made using QuantSeq three prime mRNA Seq Library Prep Kit for IlluminaLexogen,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina NovaSeq 6000,,SRP457465,,,DC-WTE1_S13.fastq,fastq,816518564.0,19556325.0,DC WTE1 S13.fastq,0:41.75,A:187091550;C:151287428;G:179967901;T:221475884;N:76695801,41,,,,187091550,151287428,179967901,221475884,76695801,SRX21515627,SRS18742879,SRA1701831,University of East Anglia|Biological Sciences,University of East Anglia,1,0.61681,,0.1874,,0.95101,,0.56879,,29,,B,,usable mapping rate,illumina,novaseq_era,3prime,poly_a,lexogen,bulk,unknown,unknown,,United Kingdom,2023-08-30,Hatching,Embryo,Blood,Hematopoietic System 32437,SRR29249474,SRX24767688,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1 only for fig4 and figsupp10,weiq10,weiq10,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-only-rep1_R1.fq.gz ABEUmax-ex1-only-rep1_R2.fq.gz,fastq fastq,6282249300.0,20940831.0,ABEUmax ex1 only rep1 R1.fq.gz,0:150 1:150,A:1756899532;C:1390175279;G:1406729636;T:1728418442;N:26411,150,150,,,1756899532,1390175279,1406729636,1728418442,26411,SRX24767688,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32438,SRR29249475,SRX24767687,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax only for fig4 and figsupp10,weiq9,weiq9,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-only-rep3_R1.fq.gz ABEUmax-only-rep3_R2.fq.gz,fastq fastq,6410258400.0,21367528.0,ABEUmax only rep3 R1.fq.gz,0:150 1:150,A:1796941092;C:1415805398;G:1424825270;T:1772660117;N:26523,150,150,,,1796941092,1415805398,1424825270,1772660117,26523,SRX24767687,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32439,SRR29249476,SRX24767686,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax only for fig4 and figsupp10,weiq8,weiq8,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-only-rep2_R1.fq.gz ABEUmax-only-rep2_R2.fq.gz,fastq fastq,7389619200.0,24632064.0,ABEUmax only rep2 R1.fq.gz,0:150 1:150,A:2026204447;C:1667867375;G:1691882291;T:2003584205;N:80882,150,150,,,2026204447,1667867375,1691882291,2003584205,80882,SRX24767686,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32440,SRR29249477,SRX24767685,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax only for fig4 and figsupp10,weiq7,weiq7,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-only-rep1_R1.fq.gz ABEUmax-only-rep1_R2.fq.gz,fastq fastq,11336033400.0,37786778.0,ABEUmax only rep1 R1.fq.gz,0:150 1:150,A:3135246137;C:2536541212;G:2564827351;T:3099296340;N:122360,150,150,,,3135246137,2536541212,2564827351,3099296340,122360,SRX24767685,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32441,SRR29249478,SRX24767684,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e only for fig4 and figsupp10,weiq6,weiq6,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-only-rep3_R1.fq.gz ABE8e-only-rep3_R2.fq.gz,fastq fastq,5719869600.0,19066232.0,ABE8e only rep3 R1.fq.gz,0:150 1:150,A:1608480551;C:1257475652;G:1266100141;T:1587789911;N:23345,150,150,,,1608480551,1257475652,1266100141,1587789911,23345,SRX24767684,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32442,SRR29249479,SRX24767683,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e only for fig4 and figsupp10,weiq5,weiq5,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-only-rep2_R1.fq.gz ABE8e-only-rep2_R2.fq.gz,fastq fastq,7391481300.0,24638271.0,ABE8e only rep2 R1.fq.gz,0:150 1:150,A:2037764745;C:1665759801;G:1685514060;T:2002411849;N:30845,150,150,,,2037764745,1665759801,1685514060,2002411849,30845,SRX24767683,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32443,SRR29249480,SRX24767682,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tp53 gRNA for figsupp10,weiq39,weiq39,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tp53-rep3_R1.fq.gz ABEUmax-ex2-tp53-rep3_R2.fq.gz,fastq fastq,5803077300.0,19343591.0,ABEUmax ex2 tp53 rep3 R1.fq.gz,0:150 1:150,A:1617761226;C:1287691319;G:1296461744;T:1601139422;N:23589,150,150,,,1617761226,1287691319,1296461744,1601139422,23589,SRX24767682,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32444,SRR29249481,SRX24767681,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tp53 gRNA for figsupp10,weiq38,weiq38,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tp53-rep2_R1.fq.gz ABEUmax-ex2-tp53-rep2_R2.fq.gz,fastq fastq,6553627800.0,21845426.0,ABEUmax ex2 tp53 rep2 R1.fq.gz,0:150 1:150,A:1823059776;C:1459120344;G:1471795924;T:1799625591;N:26165,150,150,,,1823059776,1459120344,1471795924,1799625591,26165,SRX24767681,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32445,SRR29249482,SRX24767680,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tp53 gRNA for figsupp10,weiq37,weiq37,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tp53-rep1_R1.fq.gz ABEUmax-ex2-tp53-rep1_R2.fq.gz,fastq fastq,5478292800.0,18260976.0,ABEUmax ex2 tp53 rep1 R1.fq.gz,0:150 1:150,A:1532855737;C:1211392548;G:1218403742;T:1515617884;N:22889,150,150,,,1532855737,1211392548,1218403742,1515617884,22889,SRX24767680,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32446,SRR29249483,SRX24767679,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tp53 gRNA for figsupp10,weiq36,weiq36,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tp53-rep3_R1.fq.gz ABEUmax-ex1-tp53-rep3_R2.fq.gz,fastq fastq,5702600100.0,19008667.0,ABEUmax ex1 tp53 rep3 R1.fq.gz,0:150 1:150,A:1592234548;C:1265657347;G:1274347831;T:1570335937;N:24437,150,150,,,1592234548,1265657347,1274347831,1570335937,24437,SRX24767679,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32447,SRR29249484,SRX24767678,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tp53 gRNA for figsupp10,weiq35,weiq35,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tp53-rep2_R1.fq.gz ABEUmax-ex1-tp53-rep2_R2.fq.gz,fastq fastq,5673681300.0,18912271.0,ABEUmax ex1 tp53 rep2 R1.fq.gz,0:150 1:150,A:1584159831;C:1258740162;G:1265184204;T:1565573424;N:23679,150,150,,,1584159831,1258740162,1265184204,1565573424,23679,SRX24767678,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32448,SRR29249485,SRX24767677,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tp53 gRNA for figsupp10,weiq34,weiq34,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tp53-rep1_R1.fq.gz ABEUmax-ex1-tp53-rep1_R2.fq.gz,fastq fastq,5850351900.0,19501173.0,ABEUmax ex1 tp53 rep1 R1.fq.gz,0:150 1:150,A:1637621159;C:1292895963;G:1300389598;T:1619408204;N:36976,150,150,,,1637621159,1292895963,1300389598,1619408204,36976,SRX24767677,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32449,SRR29249486,SRX24767676,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tp53 gRNA for figsupp10,weiq33,weiq33,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tp53-rep3_R1.fq.gz ABEUmax-tp53-rep3_R2.fq.gz,fastq fastq,5560424400.0,18534748.0,ABEUmax tp53 rep3 R1.fq.gz,0:150 1:150,A:1573488930;C:1210871236;G:1216440896;T:1559594579;N:28759,150,150,,,1573488930,1210871236,1216440896,1559594579,28759,SRX24767676,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32450,SRR29249487,SRX24767675,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tp53 gRNA for figsupp10,weiq32,weiq32,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tp53-rep2_R1.fq.gz ABEUmax-tp53-rep2_R2.fq.gz,fastq fastq,7064616300.0,23548721.0,ABEUmax tp53 rep2 R1.fq.gz,0:150 1:150,A:1963220033;C:1575155090;G:1588646272;T:1937565246;N:29659,150,150,,,1963220033,1575155090,1588646272,1937565246,29659,SRX24767675,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32451,SRR29249488,SRX24767674,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tp53 gRNA for figsupp10,weiq31,weiq31,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tp53-rep1_R1.fq.gz ABEUmax-tp53-rep1_R2.fq.gz,fastq fastq,5574916500.0,18583055.0,ABEUmax tp53 rep1 R1.fq.gz,0:150 1:150,A:1560082887;C:1233222110;G:1242344240;T:1539244662;N:22601,150,150,,,1560082887,1233222110,1242344240,1539244662,22601,SRX24767674,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32452,SRR29249489,SRX24767673,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e only for fig4 and figsupp10,weiq4,weiq4,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-only-rep1_R1.fq.gz ABE8e-only-rep1_R2.fq.gz,fastq fastq,6671069700.0,22236899.0,ABE8e only rep1 R1.fq.gz,0:150 1:150,A:1864009996;C:1478815930;G:1487036206;T:1841181233;N:26335,150,150,,,1864009996,1478815930,1487036206,1841181233,26335,SRX24767673,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32453,SRR29249490,SRX24767672,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tp53 gRNA for figsupp10,weiq30,weiq30,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tp53-rep3_R1.fq.gz ABE8e-tp53-rep3_R2.fq.gz,fastq fastq,5472580200.0,18241934.0,ABE8e tp53 rep3 R1.fq.gz,0:150 1:150,A:1529609161;C:1210720423;G:1218497152;T:1513730632;N:22832,150,150,,,1529609161,1210720423,1218497152,1513730632,22832,SRX24767672,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32454,SRR29249491,SRX24767671,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tp53 gRNA for figsupp10,weiq29,weiq29,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tp53-rep2_R1.fq.gz ABE8e-tp53-rep2_R2.fq.gz,fastq fastq,5775198300.0,19250661.0,ABE8e tp53 rep2 R1.fq.gz,0:150 1:150,A:1615797642;C:1277695015;G:1286105005;T:1595565162;N:35476,150,150,,,1615797642,1277695015,1286105005,1595565162,35476,SRX24767671,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32455,SRR29249492,SRX24767670,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tp53 gRNA for figsupp10,weiq28,weiq28,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tp53-rep1_R1.fq.gz ABE8e-tp53-rep1_R2.fq.gz,fastq fastq,5982304200.0,19941014.0,ABE8e tp53 rep1 R1.fq.gz,0:150 1:150,A:1664274171;C:1331728039;G:1341859951;T:1644417739;N:24300,150,150,,,1664274171,1331728039,1341859951,1644417739,24300,SRX24767670,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32456,SRR29249493,SRX24767669,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tyr g4 gRNA for fig4,weiq27,weiq27,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tyr-g4-rep3_R1.fq.gz ABEUmax-ex2-tyr-g4-rep3_R2.fq.gz,fastq fastq,6163283400.0,20544278.0,ABEUmax ex2 tyr g4 rep3 R1.fq.gz,0:150 1:150,A:1719817416;C:1368111115;G:1378451421;T:1696857842;N:45606,150,150,,,1719817416,1368111115,1378451421,1696857842,45606,SRX24767669,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32457,SRR29249494,SRX24767668,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tyr g4 gRNA for fig4,weiq26,weiq26,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tyr-g4-rep2_R1.fq.gz ABEUmax-ex2-tyr-g4-rep2_R2.fq.gz,fastq fastq,6053987100.0,20179957.0,ABEUmax ex2 tyr g4 rep2 R1.fq.gz,0:150 1:150,A:1690768868;C:1342177860;G:1354472933;T:1666542324;N:25115,150,150,,,1690768868,1342177860,1354472933,1666542324,25115,SRX24767668,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32458,SRR29249495,SRX24767667,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tyr g4 gRNA for fig4,weiq25,weiq25,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tyr-g4-rep1_R1.fq.gz ABEUmax-ex2-tyr-g4-rep1_R2.fq.gz,fastq fastq,5899971000.0,19666570.0,ABEUmax ex2 tyr g4 rep1 R1.fq.gz,0:150 1:150,A:1647942416;C:1309207091;G:1318063577;T:1624735976;N:21940,150,150,,,1647942416,1309207091,1318063577,1624735976,21940,SRX24767667,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32459,SRR29249496,SRX24767666,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tyr g4 gRNA for fig4,weiq24,weiq24,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tyr-g4-rep3_R1.fq.gz ABEUmax-ex1-tyr-g4-rep3_R2.fq.gz,fastq fastq,7437809400.0,24792698.0,ABEUmax ex1 tyr g4 rep3 R1.fq.gz,0:150 1:150,A:2076956731;C:1650332418;G:1666043372;T:2044446120;N:30759,150,150,,,2076956731,1650332418,1666043372,2044446120,30759,SRX24767666,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32460,SRR29249497,SRX24767665,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tyr g4 gRNA for fig4,weiq23,weiq23,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tyr-g4-rep2_R1.fq.gz ABEUmax-ex1-tyr-g4-rep2_R2.fq.gz,fastq fastq,9322655400.0,31075518.0,ABEUmax ex1 tyr g4 rep2 R1.fq.gz,0:150 1:150,A:2594468604;C:2077629273;G:2094178897;T:2556340809;N:37817,150,150,,,2594468604,2077629273,2094178897,2556340809,37817,SRX24767665,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32461,SRR29249498,SRX24767664,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tyr g4 gRNA for fig4,weiq22,weiq22,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tyr-g4-rep1_R1.fq.gz ABEUmax-ex1-tyr-g4-rep1_R2.fq.gz,fastq fastq,8997229800.0,29990766.0,ABEUmax ex1 tyr g4 rep1 R1.fq.gz,0:150 1:150,A:2496600223;C:2012455168;G:2029289770;T:2458847443;N:37196,150,150,,,2496600223,2012455168,2029289770,2458847443,37196,SRX24767664,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32462,SRR29249499,SRX24767663,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tyr g4 gRNA for fig4,weiq21,weiq21,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tyr-g4-rep3_R1.fq.gz ABEUmax-tyr-g4-rep3_R2.fq.gz,fastq fastq,6046479300.0,20154931.0,ABEUmax tyr g4 rep3 R1.fq.gz,0:150 1:150,A:1690489526;C:1340484296;G:1343425025;T:1672042239;N:38214,150,150,,,1690489526,1340484296,1343425025,1672042239,38214,SRX24767663,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32463,SRR29249500,SRX24767662,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of un injected control for fig4 and figsupp10,weiq3,weiq3,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,blank-rep3_R1.fq.gz blank-rep3_R2.fq.gz,fastq fastq,5916067800.0,19720226.0,blank rep3 R1.fq.gz,0:150 1:150,A:1654283259;C:1308680421;G:1317350949;T:1635716655;N:36516,150,150,,,1654283259,1308680421,1317350949,1635716655,36516,SRX24767662,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32464,SRR29249501,SRX24767661,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tyr g4 gRNA for fig4,weiq20,weiq20,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tyr-g4-rep2_R1.fq.gz ABEUmax-tyr-g4-rep2_R2.fq.gz,fastq fastq,9783360000.0,32611200.0,ABEUmax tyr g4 rep2 R1.fq.gz,0:150 1:150,A:2719027222;C:2183139548;G:2202789910;T:2678363595;N:39725,150,150,,,2719027222,2183139548,2202789910,2678363595,39725,SRX24767661,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32465,SRR29249502,SRX24767660,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tyr g4 gRNA for fig4,weiq19,weiq19,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tyr-g4-rep1_R1.fq.gz ABEUmax-tyr-g4-rep1_R2.fq.gz,fastq fastq,6132960900.0,20443203.0,ABEUmax tyr g4 rep1 R1.fq.gz,0:150 1:150,A:1713443234;C:1359953330;G:1369858637;T:1689667341;N:38358,150,150,,,1713443234,1359953330,1369858637,1689667341,38358,SRX24767660,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32466,SRR29249503,SRX24767659,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tyr g4 gRNA for fig4,weiq18,weiq18,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tyr-g4-rep3_R1.fq.gz ABE8e-tyr-g4-rep3_R2.fq.gz,fastq fastq,10563257400.0,35210858.0,ABE8e tyr g4 rep3 R1.fq.gz,0:150 1:150,A:2936805440;C:2355014311;G:2373187903;T:2898205803;N:43943,150,150,,,2936805440,2355014311,2373187903,2898205803,43943,SRX24767659,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32467,SRR29249504,SRX24767658,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tyr g4 gRNA for fig4,weiq17,weiq17,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tyr-g4-rep2_R1.fq.gz ABE8e-tyr-g4-rep2_R2.fq.gz,fastq fastq,6284594400.0,20948648.0,ABE8e tyr g4 rep2 R1.fq.gz,0:150 1:150,A:1749704654;C:1397878340;G:1413270817;T:1723715159;N:25430,150,150,,,1749704654,1397878340,1413270817,1723715159,25430,SRX24767658,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32468,SRR29249505,SRX24767657,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tyr g4 gRNA for fig4,weiq16,weiq16,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tyr-g4-rep1_R1.fq.gz ABE8e-tyr-g4-rep1_R2.fq.gz,fastq fastq,6074610900.0,20248703.0,ABE8e tyr g4 rep1 R1.fq.gz,0:150 1:150,A:1685268364;C:1357083683;G:1371702610;T:1660530508;N:25735,150,150,,,1685268364,1357083683,1371702610,1660530508,25735,SRX24767657,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32469,SRR29249506,SRX24767656,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2 only for fig4 and figsupp10,weiq15,weiq15,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-only-rep3_R1.fq.gz ABEUmax-ex2-only-rep3_R2.fq.gz,fastq fastq,8344627500.0,27815425.0,ABEUmax ex2 only rep3 R1.fq.gz,0:150 1:150,A:2329541832;C:1850818895;G:1863621349;T:2300610494;N:34930,150,150,,,2329541832,1850818895,1863621349,2300610494,34930,SRX24767656,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32470,SRR29249507,SRX24767655,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2 only for fig4 and figsupp10,weiq14,weiq14,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-only-rep2_R1.fq.gz ABEUmax-ex2-only-rep2_R2.fq.gz,fastq fastq,5572436400.0,18574788.0,ABEUmax ex2 only rep2 R1.fq.gz,0:150 1:150,A:1553125380;C:1238548658;G:1250549536;T:1530189551;N:23275,150,150,,,1553125380,1238548658,1250549536,1530189551,23275,SRX24767655,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32471,SRR29249508,SRX24767654,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2 only for fig4 and figsupp10,weiq13,weiq13,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-only-rep1_R1.fq.gz ABEUmax-ex2-only-rep1_R2.fq.gz,fastq fastq,5559912900.0,18533043.0,ABEUmax ex2 only rep1 R1.fq.gz,0:150 1:150,A:1557612759;C:1229187540;G:1236208646;T:1536881156;N:22799,150,150,,,1557612759,1229187540,1236208646,1536881156,22799,SRX24767654,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32472,SRR29249509,SRX24767653,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1 only for fig4 and figsupp10,weiq12,weiq12,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-only-rep3_R1.fq.gz ABEUmax-ex1-only-rep3_R2.fq.gz,fastq fastq,8929598100.0,29765327.0,ABEUmax ex1 only rep3 R1.fq.gz,0:150 1:150,A:2488796078;C:1985527444;G:2002596512;T:2452641331;N:36735,150,150,,,2488796078,1985527444,2002596512,2452641331,36735,SRX24767653,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32473,SRR29249510,SRX24767652,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1 only for fig4 and figsupp10,weiq11,weiq11,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-only-rep2_R1.fq.gz ABEUmax-ex1-only-rep2_R2.fq.gz,fastq fastq,5984311200.0,19947704.0,ABEUmax ex1 only rep2 R1.fq.gz,0:150 1:150,A:1677434145;C:1320957982;G:1334799050;T:1651095011;N:25012,150,150,,,1677434145,1320957982,1334799050,1651095011,25012,SRX24767652,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32474,SRR29249511,SRX24767651,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of un injected control for fig4 and figsupp10,weiq2,weiq2,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,blank-rep2_R1.fq.gz blank-rep2_R2.fq.gz,fastq fastq,5470137600.0,18233792.0,blank rep2 R1.fq.gz,0:150 1:150,A:1521716947;C:1217660080;G:1226314116;T:1504423565;N:22892,150,150,,,1521716947,1217660080,1226314116,1504423565,22892,SRX24767651,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32475,SRR29249512,SRX24767650,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of un injected control for fig4 and figsupp10,weiq1,weiq1,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,blank-rep1_R1.fq.gz blank-rep1_R2.fq.gz,fastq fastq,5844893700.0,19482979.0,blank rep1 R1.fq.gz,0:150 1:150,A:1627504221;C:1298537202;G:1308079845;T:1610735356;N:37076,150,150,,,1627504221,1298537202,1308079845,1610735356,37076,SRX24767650,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 50883,SRR8784477,SRX5574338,SRS4536896,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,Control F 48 3 S1,,strain:5D|isolate:23|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Control F 48 3 S1,Control F 48 3 S1,Control F 48 3 S1,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,F-48-3_S1_L001_R1_001.fastq.gz,fastq,67830713.0,899986.0,F 48 3 S1 L001 R1 001.fastq.gz,0:75.37 1:0,A:20791010;C:12783016;G:16828743;T:17410679;N:17265,75,0,,,20791010,12783016,16828743,17410679,17265,SRX5574338,SRS4536896,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.79022,,0.25396,,0.79437,,0.53266,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50884,SRR8784478,SRX5574337,SRS4536895,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,Control F 48 3 2 S3,,strain:5D|isolate:24|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Control F 48 3 2 S3,Control F 48 3 2 S3,Control F 48 3 2 S3,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,F-48-3-2_S3_L001_R1_001.fastq.gz,fastq,213142249.0,2830433.0,F 48 3 2 S3 L001 R1 001.fastq.gz,0:75.30 1:0,A:65944717;C:40637502;G:51838475;T:54647248;N:74307,75,0,,,65944717,40637502,51838475,54647248,74307,SRX5574337,SRS4536895,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.79404,,0.25196,,0.79395,,0.53905,,73,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50885,SRR8784479,SRX5574336,SRS4536894,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,Control F 48 2 S2,,strain:5D|isolate:21|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Control F 48 2 S2,Control F 48 2 S2,Control F 48 2 S2,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,F-48-2_S2_L001_R1_001.fastq.gz,fastq,178747420.0,2376837.0,F 48 2 S2 L001 R1 001.fastq.gz,0:75.20 1:0,A:59901560;C:31310355;G:44897697;T:42384622;N:253186,75,0,,,59901560,31310355,44897697,42384622,253186,SRX5574336,SRS4536894,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.71338,,0.21378,,0.81217,,0.41305,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50886,SRR8784480,SRX5574335,SRS4536893,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,Control F 48 2 2 S6,,strain:5D|isolate:22|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Control F 48 2 2 S6,Control F 48 2 2 S6,Control F 48 2 2 S6,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,F-48-2-2_S6_L001_R1_001.fastq.gz,fastq,400819899.0,5339776.0,F 48 2 2 S6 L001 R1 001.fastq.gz,0:75.06 1:0,A:136365829;C:72050772;G:96833546;T:94932770;N:636982,75,0,,,136365829,72050772,96833546,94932770,636982,SRX5574335,SRS4536893,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.71632,,0.21103,,0.81207,,0.41507,,73,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50893,SRR8784487,SRX5574328,SRS4536886,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,DPHP D 48 1 2 S11,,strain:5D|isolate:8|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,DPHP D 48 1 2 S11,DPHP D 48 1 2 S11,DPHP D 48 1 2 S11,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,D-48-1-2_S11_L001_R1_001.fastq.gz,fastq,293965246.0,3908349.0,D 48 1 2 S11 L001 R1 001.fastq.gz,0:75.21 1:0,A:91755488;C:55695879;G:73318318;T:72986235;N:209326,75,0,,,91755488,55695879,73318318,72986235,209326,SRX5574328,SRS4536886,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.75994,,0.21887,,0.79795,,0.49683,,73,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50894,SRR8784488,SRX5574327,SRS4536885,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,DPHP D 48 1 S9,,strain:5D|isolate:7|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,DPHP D 48 1 S9,DPHP D 48 1 S9,DPHP D 48 1 S9,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,D-48-1_S9_L001_R1_001.fastq.gz,fastq,191714492.0,2546032.0,D 48 1 S9 L001 R1 001.fastq.gz,0:75.30 1:0,A:59195158;C:35809295;G:48950026;T:47650406;N:109607,75,0,,,59195158,35809295,48950026,47650406,109607,SRX5574327,SRS4536885,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.75847,,0.22188,,0.79685,,0.4968,,73,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50895,SRR8784489,SRX5574326,SRS4536884,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,DPHP D 48 2 2 S7,,strain:5D|isolate:10|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,DPHP D 48 2 2 S7,DPHP D 48 2 2 S7,DPHP D 48 2 2 S7,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,D-48-2-2_S7_L001_R1_001.fastq.gz,fastq,155583883.0,2087810.0,D 48 2 2 S7 L001 R1 001.fastq.gz,0:74.52 1:0,A:49598865;C:28228787;G:36091978;T:40301675;N:1362578,74,0,,,49598865,28228787,36091978,40301675,1362578,SRX5574326,SRS4536884,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.77212,,0.1745,,0.78859,,0.41944,,73,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50896,SRR8784490,SRX5574325,SRS4536883,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,DPHP D 48 2 S8,,strain:5D|isolate:9|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,DPHP D 48 2 S8,DPHP D 48 2 S8,DPHP D 48 2 S8,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,D-48-2_S8_L001_R1_001.fastq.gz,fastq,132230474.0,1772522.0,D 48 2 S8 L001 R1 001.fastq.gz,0:74.60 1:0,A:41615555;C:23617575;G:31492887;T:34345947;N:1158510,74,0,,,41615555,23617575,31492887,34345947,1158510,SRX5574325,SRS4536883,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.76974,,0.17747,,0.78742,,0.41654,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50897,SRR8784491,SRX5574324,SRS4536882,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,Control F 48 1 2 S4,,strain:5D|isolate:20|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Control F 48 1 2 S4,Control F 48 1 2 S4,Control F 48 1 2 S4,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,F-48-1-2_S4_L001_R1_001.fastq.gz,fastq,255149752.0,3390672.0,F 48 1 2 S4 L001 R1 001.fastq.gz,0:75.25 1:0,A:84109484;C:45905271;G:59237068;T:65769813;N:128116,75,0,,,84109484,45905271,59237068,65769813,128116,SRX5574324,SRS4536882,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.7718,,0.21374,,0.79395,,0.54195,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50898,SRR8784492,SRX5574323,SRS4536881,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,Control F 48 1 S3,,strain:5D|isolate:19|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Control F 48 1 S3,Control F 48 1 S3,Control F 48 1 S3,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,F-48-1_S3_L001_R1_001.fastq.gz,fastq,147407439.0,1956683.0,F 48 1 S3 L001 R1 001.fastq.gz,0:75.34 1:0,A:47948642;C:26154006;G:35169552;T:38083376;N:51863,75,0,,,47948642,26154006,35169552,38083376,51863,SRX5574323,SRS4536881,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.77371,,0.21789,,0.79149,,0.54916,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50901,SRR8784495,SRX5574320,SRS4536878,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,DPHP D 48 3 2 S9,,strain:5D|isolate:12|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,DPHP D 48 3 2 S9,DPHP D 48 3 2 S9,DPHP D 48 3 2 S9,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,D-48-3-2_S9_L001_R1_001.fastq.gz,fastq,148782995.0,1984474.0,D 48 3 2 S9 L001 R1 001.fastq.gz,0:74.97 1:0,A:46510234;C:26367032;G:34603075;T:40681699;N:620955,74,0,,,46510234,26367032,34603075,40681699,620955,SRX5574320,SRS4536878,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.81586,,0.21364,,0.78924,,0.52566,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 50902,SRR8784496,SRX5574319,SRS4536877,SRP189394,PRJNA511154,Diphenyl Phosphate Induced Toxicity During Embryonic Development,PRJNA511154,Other,The objective of this project was to rely on mRNA sequencing to determine the potential impacts of diphenyl phosphate DPHP on the embryonic transcriptome in zebrafish.,,,,,DPHP D 48 3 S7,,strain:5D|isolate:11|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,DPHP D 48 3 S7,DPHP D 48 3 S7,DPHP D 48 3 S7,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP189394,,,D-48-3_S7_L001_R1_001.fastq.gz,fastq,98806235.0,1314290.0,D 48 3 S7 L001 R1 001.fastq.gz,0:75.18 1:0,A:30623195;C:17350999;G:23497158;T:27094108;N:240775,75,0,,,30623195,17350999,23497158,27094108,240775,SRX5574319,SRS4536877,SRA865872,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.81791,,0.21548,,0.78737,,0.52902,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-03-25,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51763,SRR9850643,SRX6605290,SRS5170119,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,TPHP 48H 3 S2 rep2,,strain:5D|isolate:24|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,TPHP 48H 3 S2 rep2,TPHP 48H 3 S2 rep2,TPHP 48H 3 S2 rep2,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,TPHP-48H-3_S2_L001_R1_001-rep2.fastq.gz,fastq,201995837.0,2701581.0,TPHP 48H 3 S2 L001 R1 001 rep2.fastq.gz,0:74.77 1:0,A:67014042;C:36598764;G:54981173;T:42698036;N:703822,74,0,,,67014042,36598764,54981173,42698036,703822,SRX6605290,SRS5170119,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.79197,,0.18414,,0.81968,,0.4218,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51764,SRR9850644,SRX6605289,SRS5170118,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,TPHP 48H 2 S6 rep2,,strain:5D|isolate:23|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,TPHP 48H 2 S6 rep2,TPHP 48H 2 S6 rep2,TPHP 48H 2 S6 rep2,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,TPHP-48H-2_S6_L001_R1_001-rep2.fastq.gz,fastq,237937174.0,3171719.0,TPHP 48H 2 S6 L001 R1 001 rep2.fastq.gz,0:75.02 1:0,A:75987327;C:43579240;G:62871882;T:54972471;N:526254,75,0,,,75987327,43579240,62871882,54972471,526254,SRX6605289,SRS5170118,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.82441,,0.18389,,0.80667,,0.53872,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51765,SRR9850645,SRX6605288,SRS5170117,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,TPHP 48H 1 S7 rep2,,strain:5D|isolate:22|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,TPHP 48H 1 S7 rep2,TPHP 48H 1 S7 rep2,TPHP 48H 1 S7 rep2,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,TPHP-48H-1_S7_L001_R1_001-rep2.fastq.gz,fastq,259624910.0,3459099.0,TPHP 48H 1 S7 L001 R1 001 rep2.fastq.gz,0:75.06 1:0,A:82187879;C:48739574;G:69115001;T:59075587;N:506869,75,0,,,82187879,48739574,69115001,59075587,506869,SRX6605288,SRS5170117,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.81857,,0.19343,,0.80773,,0.55611,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51766,SRR9850646,SRX6605287,SRS5170116,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC 48H 3 S8 rep2,,strain:5D|isolate:21|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC 48H 3 S8 rep2,VC 48H 3 S8 rep2,VC 48H 3 S8 rep2,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-48H-3_S8_L001_R1_001-rep2.fastq.gz,fastq,236717158.0,3155023.0,VC 48H 3 S8 L001 R1 001 rep2.fastq.gz,0:75.03 1:0,A:74228713;C:43856163;G:64911646;T:53204626;N:516010,75,0,,,74228713,43856163,64911646,53204626,516010,SRX6605287,SRS5170116,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.82314,,0.20213,,0.81241,,0.55521,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51767,SRR9850647,SRX6605286,SRS5170115,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC TPHP 2 S9,,strain:5D|isolate:28|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC TPHP 2 S9,VC TPHP 2 S9,VC TPHP 2 S9,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-TPHP-2_S9_L001_R1_001.fastq.gz,fastq,199384374.0,2647253.0,VC TPHP 2 S9 L001 R1 001.fastq.gz,0:75.32 1:0,A:65198333;C:36123275;G:58091856;T:39708521;N:262389,75,0,,,65198333,36123275,58091856,39708521,262389,SRX6605286,SRS5170115,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.74469,,0.21127,,0.82773,,0.52603,,74,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51768,SRR9850648,SRX6605285,SRS5170114,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC VC 4 S4,,strain:5D|isolate:27|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC VC 4 S4,VC VC 4 S4,VC VC 4 S4,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-VC-4_S4_L001_R1_001.fastq.gz,fastq,174435858.0,2316755.0,VC VC 4 S4 L001 R1 001.fastq.gz,0:75.29 1:0,A:56318890;C:32432910;G:53400640;T:31998238;N:285180,75,0,,,56318890,32432910,53400640,31998238,285180,SRX6605285,SRS5170114,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.71098,,0.21811,,0.83802,,0.51636,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51769,SRR9850649,SRX6605284,SRS5170113,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC VC 3 S5,,strain:5D|isolate:26|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC VC 3 S5,VC VC 3 S5,VC VC 3 S5,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-VC-3_S5_L001_R1_001.fastq.gz,fastq,188909242.0,2510999.0,VC VC 3 S5 L001 R1 001.fastq.gz,0:75.23 1:0,A:61959379;C:35003479;G:58918178;T:32665548;N:362658,75,0,,,61959379,35003479,58918178,32665548,362658,SRX6605284,SRS5170113,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.67982,,0.21678,,0.84784,,0.51214,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51770,SRR9850650,SRX6605283,SRS5170112,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC VC 2 S6,,strain:5D|isolate:25|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC VC 2 S6,VC VC 2 S6,VC VC 2 S6,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-VC-2_S6_L001_R1_001.fastq.gz,fastq,176012572.0,2340459.0,VC VC 2 S6 L001 R1 001.fastq.gz,0:75.20 1:0,A:58784547;C:32281434;G:53236739;T:31304666;N:405186,75,0,,,58784547,32281434,53236739,31304666,405186,SRX6605283,SRS5170112,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.66412,,0.21267,,0.84715,,0.52563,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51771,SRR9850651,SRX6605282,SRS5170111,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC TPHP 4 S3,,strain:5D|isolate:30|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC TPHP 4 S3,VC TPHP 4 S3,VC TPHP 4 S3,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-TPHP-4_S3_L001_R1_001.fastq.gz,fastq,198591893.0,2637096.0,VC TPHP 4 S3 L001 R1 001.fastq.gz,0:75.31 1:0,A:63292645;C:37556711;G:58712345;T:38706966;N:323226,75,0,,,63292645,37556711,58712345,38706966,323226,SRX6605282,SRS5170111,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.76187,,0.22734,,0.82976,,0.55256,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51772,SRR9850652,SRX6605281,SRS5170110,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC TPHP 3 S8,,strain:5D|isolate:29|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC TPHP 3 S8,VC TPHP 3 S8,VC TPHP 3 S8,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-TPHP-3_S8_L001_R1_001.fastq.gz,fastq,203921739.0,2708310.0,VC TPHP 3 S8 L001 R1 001.fastq.gz,0:75.29 1:0,A:66237102;C:37376888;G:61215074;T:38822457;N:270218,75,0,,,66237102,37376888,61215074,38822457,270218,SRX6605281,SRS5170110,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.7527,,0.23665,,0.83688,,0.54049,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51773,SRR9850653,SRX6605280,SRS5170109,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC 48H 1 S9 rep2,,strain:5D|isolate:19|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC 48H 1 S9 rep2,VC 48H 1 S9 rep2,VC 48H 1 S9 rep2,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-48H-1_S9_L001_R1_001-rep2.fastq.gz,fastq,211730791.0,2815458.0,VC 48H 1 S9 L001 R1 001 rep2.fastq.gz,0:75.20 1:0,A:65857312;C:39323343;G:54273645;T:51994380;N:282111,75,0,,,65857312,39323343,54273645,51994380,282111,SRX6605280,SRS5170109,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.84131,,0.16747,,0.79243,,0.53352,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51774,SRR9850654,SRX6605279,SRS5170108,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC 48H 2 S1 rep2,,strain:5D|isolate:20|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC 48H 2 S1 rep2,VC 48H 2 S1 rep2,VC 48H 2 S1 rep2,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-48H-2_S1_L001_R1_001-rep2.fastq.gz,fastq,276347859.0,3678301.0,VC 48H 2 S1 L001 R1 001 rep2.fastq.gz,0:75.13 1:0,A:89381404;C:50794394;G:68201065;T:67570788;N:400208,75,0,,,89381404,50794394,68201065,67570788,400208,SRX6605279,SRS5170108,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.81548,,0.15154,,0.7949,,0.54568,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51777,SRR9850657,SRX6605276,SRS5170105,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,TPHP 48H 2 S5 rep1,,strain:5D|isolate:11|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,TPHP 48H 2 S5 rep1,TPHP 48H 2 S5 rep1,TPHP 48H 2 S5 rep1,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,TPHP-48H-2_S5_L001_R1_001-rep1.fastq.gz,fastq,271642273.0,3621627.0,TPHP 48H 2 S5 L001 R1 001 rep1.fastq.gz,0:75.01 1:0,A:86858635;C:49734281;G:71737286;T:62690364;N:621707,75,0,,,86858635,49734281,71737286,62690364,621707,SRX6605276,SRS5170105,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.82392,,0.18068,,0.8046,,0.54068,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51778,SRR9850658,SRX6605275,SRS5170104,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,TPHP 48H 3 S11 rep1,,strain:5D|isolate:12|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,TPHP 48H 3 S11 rep1,TPHP 48H 3 S11 rep1,TPHP 48H 3 S11 rep1,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,TPHP-48H-3_S11_L001_R1_001-rep1.fastq.gz,fastq,224100023.0,2997207.0,TPHP 48H 3 S11 L001 R1 001 rep1.fastq.gz,0:74.77 1:0,A:74104392;C:40748081;G:60694642;T:47776381;N:776527,74,0,,,74104392,40748081,60694642,47776381,776527,SRX6605275,SRS5170104,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.79189,,0.18002,,0.81884,,0.42667,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51783,SRR9850663,SRX6605270,SRS5170099,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,Fen TPHP 4 S10,,strain:5D|isolate:36|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Fen TPHP 4 S10,Fen TPHP 4 S10,Fen TPHP 4 S10,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,Fen-TPHP-4_S10_L001_R1_001.fastq.gz,fastq,196564407.0,2610999.0,Fen TPHP 4 S10 L001 R1 001.fastq.gz,0:75.28 1:0,A:63609341;C:36935396;G:58278486;T:37392277;N:348907,75,0,,,63609341,36935396,58278486,37392277,348907,SRX6605270,SRS5170099,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.75358,,0.22237,,0.84062,,0.54272,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51784,SRR9850664,SRX6605269,SRS5170098,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC 48H 3 S2 rep1,,strain:5D|isolate:9|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC 48H 3 S2 rep1,VC 48H 3 S2 rep1,VC 48H 3 S2 rep1,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-48H-3_S2_L001_R1_001-rep1.fastq.gz,fastq,242109969.0,3227328.0,VC 48H 3 S2 L001 R1 001 rep1.fastq.gz,0:75.02 1:0,A:75877759;C:44887861;G:66514567;T:54272434;N:557348,75,0,,,75877759,44887861,66514567,54272434,557348,SRX6605269,SRS5170098,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.82055,,0.20178,,0.81314,,0.56014,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51785,SRR9850665,SRX6605268,SRS5170097,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,TPHP 48H 1 S1 rep1,,strain:5D|isolate:10|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,TPHP 48H 1 S1 rep1,TPHP 48H 1 S1 rep1,TPHP 48H 1 S1 rep1,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,TPHP-48H-1_S1_L001_R1_001-rep1.fastq.gz,fastq,252123274.0,3359474.0,TPHP 48H 1 S1 L001 R1 001 rep1.fastq.gz,0:75.05 1:0,A:79801702;C:47334230;G:67068942;T:57405454;N:512946,75,0,,,79801702,47334230,67068942,57405454,512946,SRX6605268,SRS5170097,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.81773,,0.19121,,0.80608,,0.54303,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51786,SRR9850666,SRX6605267,SRS5170096,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,Fen TPHP 3 S12,,strain:5D|isolate:35|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Fen TPHP 3 S12,Fen TPHP 3 S12,Fen TPHP 3 S12,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,Fen-TPHP-3_S12_L001_R1_001.fastq.gz,fastq,199843928.0,2656141.0,Fen TPHP 3 S12 L001 R1 001.fastq.gz,0:75.24 1:0,A:65777506;C:37094681;G:60821232;T:35697572;N:452937,75,0,,,65777506,37094681,60821232,35697572,452937,SRX6605267,SRS5170096,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.71894,,0.2103,,0.84711,,0.545,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51791,SRR9850671,SRX6605262,SRS5170091,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC 48H 1 S3 rep1,,strain:5D|isolate:7|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC 48H 1 S3 rep1,VC 48H 1 S3 rep1,VC 48H 1 S3 rep1,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-48H-1_S3_L001_R1_001-rep1.fastq.gz,fastq,199373608.0,2651116.0,VC 48H 1 S3 L001 R1 001 rep1.fastq.gz,0:75.20 1:0,A:62058387;C:37016205;G:51022592;T:48998357;N:278067,75,0,,,62058387,37016205,51022592,48998357,278067,SRX6605262,SRS5170091,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.83767,,0.16453,,0.79243,,0.53282,,73,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51792,SRR9850672,SRX6605261,SRS5170090,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,VC 48H 2 S8 rep1,,strain:5D|isolate:8|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,VC 48H 2 S8 rep1,VC 48H 2 S8 rep1,VC 48H 2 S8 rep1,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,VC-48H-2_S8_L001_R1_001-rep1.fastq.gz,fastq,236060090.0,3142163.0,VC 48H 2 S8 L001 R1 001 rep1.fastq.gz,0:75.13 1:0,A:76374701;C:43421323;G:58231468;T:57673311;N:359287,75,0,,,76374701,43421323,58231468,57673311,359287,SRX6605261,SRS5170090,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.81274,,0.15288,,0.79596,,0.54677,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51795,SRR9850675,SRX6605258,SRS5170087,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,Fen VC 2 S2,,strain:5D|isolate:31|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Fen VC 2 S2,Fen VC 2 S2,Fen VC 2 S2,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,Fen-VC-2_S2_L001_R1_001.fastq.gz,fastq,213923713.0,2847805.0,Fen VC 2 S2 L001 R1 001.fastq.gz,0:75.12 1:0,A:69793245;C:38187626;G:70282310;T:35037868;N:622664,75,0,,,69793245,38187626,70282310,35037868,622664,SRX6605258,SRS5170087,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.67115,,0.23332,,0.86028,,0.51162,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51796,SRR9850676,SRX6605257,SRS5170086,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,Fen VC 3 S7,,strain:5D|isolate:32|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Fen VC 3 S7,Fen VC 3 S7,Fen VC 3 S7,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,Fen-VC-3_S7_L001_R1_001.fastq.gz,fastq,183177986.0,2432127.0,Fen VC 3 S7 L001 R1 001.fastq.gz,0:75.32 1:0,A:58937811;C:33649799;G:54160481;T:36179359;N:250536,75,0,,,58937811,33649799,54160481,36179359,250536,SRX6605257,SRS5170086,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.7458,,0.21388,,0.83108,,0.54862,,75,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51797,SRR9850677,SRX6605256,SRS5170085,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,Fen VC 4 S1,,strain:5D|isolate:33|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Fen VC 4 S1,Fen VC 4 S1,Fen VC 4 S1,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,Fen-VC-4_S1_L001_R1_001.fastq.gz,fastq,199039773.0,2642212.0,Fen VC 4 S1 L001 R1 001.fastq.gz,0:75.33 1:0,A:62965541;C:38429612;G:58610294;T:38798412;N:235914,75,0,,,62965541,38429612,58610294,38798412,235914,SRX6605256,SRS5170085,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.75416,,0.25114,,0.83347,,0.57992,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 51798,SRR9850678,SRX6605255,SRS5170084,SRP216607,PRJNA529921,mRNA Sequencing Identifies Liver as a Potential Target Organ for Triphenyl Phosphate in Embryonic Zebrafish,PRJNA529921,Other,The objectives of this study were to 1 rely on mRNA sequencing to identify pathways before and post cardiac looping 30 hpf and 48 hpf respectively that may be impacted following exposure to 10 µM TPHP from 24 hpf 48 hpf and 2 determine whether pre treatment with 2 µM fenretinide from 24 hpf 30 hpf mitigates cardiotoxicity related pathways within embryos exposed to TPHP from xxx 48 hpf.,,,,,Fen TPHP 2 S11,,strain:5D|isolate:34|dev stage:48 hpf|sex:not applicable|tissue:embryo|BioSampleModel:Model organism or animal,,,,,,,,,Fen TPHP 2 S11,Fen TPHP 2 S11,Fen TPHP 2 S11,QuantSeq three prime mRNA Seq Library Prep Kit FWD,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina MiniSeq,,SRP216607,,,Fen-TPHP-2_S11_L001_R1_001.fastq.gz,fastq,182345016.0,2422305.0,Fen TPHP 2 S11 L001 R1 001.fastq.gz,0:75.28 1:0,A:58172182;C:32950553;G:56399463;T:34467517;N:355301,75,0,,,58172182,32950553,56399463,34467517,355301,SRX6605255,SRS5170084,SRA928015,"University of California, Riverside|Environmental Sciences","University of California, Riverside",1,0.73784,,0.22193,,0.84027,,0.45083,,76,,B,,usable mapping rate,illumina,miseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,United States,2019-07-28,Hatching,Embryo,Embryo Imprecise,All anatomical structures 55536,SRR10532692,SRX7216663,SRS5719129,SRP233258,PRJNA591815,Ago2 dependent processing allows miR 451 to evade the global microRNA turnover elicited during erythropoiesis,PRJNA591815,Other,MicroRNAs are sequentially processed by two RNAse III enzymes Drosha and Dicer. miR 451 is the only known miRNA whose processing bypasses Dicer and instead relies on the slicer activity of Argonaute 2 Ago2. MiR 451 is highly conserved in vertebrates and regulates erythrocyte maturation where it becomes the most abundant miRNA. However the basis for the non canonical biogenesis of miR 451 is unclear. In this study we tested the hypothesis that miR 144 represses Dicer in a negative feedback loop during erythropoiesis and enhances miR 451 biogenesis. Loss of miR 144 mediated Dicer repression in zebrafish embryos and human cells leads to increased canonical miRNA production and impaired miR 451 maturation.,,,,,miR 451 mutant,,isolate:Lab reared|age:2 days|sex:not applicable|tissue:peripheral blood|genotype:miR 451 / |phenotype:wild type|treatment:n1|BioSampleModel:Model organism or animal,,,,,,,,,Transcriptomic profiling of peripheral blood from 2 dpf zebrafish embryos,mRNA Mut miR 451,mRNA Mut miR 451,mRNA libraries were cloned from polyA+ RNA isolated from peripheral blood of 2 dpf WT and mutant zebrafish embryos according to Illumina TruSeq protocol. Libraries were cloned and sequenced at Boston University Microarray and Sequencing core.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP233258,,,mRNA-miR-451.fastq.gz,fastq,7904410367.0,104613601.0,mRNA miR 451.fastq.gz,0:75.56 1:0,A:1795110678;C:2004074141;G:2113982350;T:1989843693;N:1399505,75,0,,,1795110678,2004074141,2113982350,1989843693,1399505,SRX7216663,SRS5719129,SRA1002853,University of East Anglia|Biological Sciences,University of East Anglia,1,0.97314,,0.03847,,0.81744,,0.4673,,75,,B,,usable mapping rate,illumina,nextseq,unknown,poly_a,trueseq,bulk,unknown,unknown,,United Kingdom,2019-11-26,Hatching,Embryo,Blood,Hematopoietic System 55537,SRR10532693,SRX7216662,SRS5719128,SRP233258,PRJNA591815,Ago2 dependent processing allows miR 451 to evade the global microRNA turnover elicited during erythropoiesis,PRJNA591815,Other,MicroRNAs are sequentially processed by two RNAse III enzymes Drosha and Dicer. miR 451 is the only known miRNA whose processing bypasses Dicer and instead relies on the slicer activity of Argonaute 2 Ago2. MiR 451 is highly conserved in vertebrates and regulates erythrocyte maturation where it becomes the most abundant miRNA. However the basis for the non canonical biogenesis of miR 451 is unclear. In this study we tested the hypothesis that miR 144 represses Dicer in a negative feedback loop during erythropoiesis and enhances miR 451 biogenesis. Loss of miR 144 mediated Dicer repression in zebrafish embryos and human cells leads to increased canonical miRNA production and impaired miR 451 maturation.,,,,,miR 144 mutant,,isolate:Lab reared|age:2 days|sex:not applicable|tissue:peripheral blood|genotype:miR 144 / |phenotype:wild type|treatment:n1|BioSampleModel:Model organism or animal,,,,,,,,,Transcriptomic profiling of peripheral blood from 2 dpf zebrafish embryos,mRNA Mut miR 144,mRNA Mut miR 144,mRNA libraries were cloned from polyA+ RNA isolated from peripheral blood of 2 dpf WT and mutant zebrafish embryos according to Illumina TruSeq protocol. Libraries were cloned and sequenced at Boston University Microarray and Sequencing core.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP233258,,,mRNA-miR-144.fastq.gz,fastq,21666521349.0,286736059.0,mRNA miR 144.fastq.gz,0:75.56 1:0,A:4937891523;C:5429635867;G:5884853915;T:5410789187;N:3350857,75,0,,,4937891523,5429635867,5884853915,5410789187,3350857,SRX7216662,SRS5719128,SRA1002853,University of East Anglia|Biological Sciences,University of East Anglia,1,0.97729,,0.02379,,0.84102,,0.45517,,76,,B,,usable mapping rate,illumina,nextseq,unknown,poly_a,trueseq,bulk,unknown,unknown,,United Kingdom,2019-11-26,Hatching,Embryo,Blood,Hematopoietic System 55538,SRR10532694,SRX7216661,SRS5719127,SRP233258,PRJNA591815,Ago2 dependent processing allows miR 451 to evade the global microRNA turnover elicited during erythropoiesis,PRJNA591815,Other,MicroRNAs are sequentially processed by two RNAse III enzymes Drosha and Dicer. miR 451 is the only known miRNA whose processing bypasses Dicer and instead relies on the slicer activity of Argonaute 2 Ago2. MiR 451 is highly conserved in vertebrates and regulates erythrocyte maturation where it becomes the most abundant miRNA. However the basis for the non canonical biogenesis of miR 451 is unclear. In this study we tested the hypothesis that miR 144 represses Dicer in a negative feedback loop during erythropoiesis and enhances miR 451 biogenesis. Loss of miR 144 mediated Dicer repression in zebrafish embryos and human cells leads to increased canonical miRNA production and impaired miR 451 maturation.,,,,,wild type,,isolate:Lab reared|age:2 days|sex:not applicable|tissue:peripheral blood|genotype:wild type|phenotype:wild type|treatment:n1|BioSampleModel:Model organism or animal,,,,,,,,,Transcriptomic profiling of peripheral blood from 2 dpf zebrafish embryos,mRNA WT,mRNA WT,mRNA libraries were cloned from polyA+ RNA isolated from peripheral blood of 2 dpf WT and mutant zebrafish embryos according to Illumina TruSeq protocol. Libraries were cloned and sequenced at Boston University Microarray and Sequencing core.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP233258,,,mRNA-WT.fastq.gz,fastq,5359234061.0,70925969.0,mRNA WT.fastq.gz,0:75.56 1:0,A:1229417939;C:1341096472;G:1448568683;T:1339375309;N:775658,75,0,,,1229417939,1341096472,1448568683,1339375309,775658,SRX7216661,SRS5719127,SRA1002853,University of East Anglia|Biological Sciences,University of East Anglia,1,0.97314,,0.02809,,0.83179,,0.40499,,75,,B,,usable mapping rate,illumina,nextseq,unknown,poly_a,trueseq,bulk,unknown,unknown,,United Kingdom,2019-11-26,Hatching,Embryo,Blood,Hematopoietic System 57271,SRR12577970,SRX9064853,SRS7314026,SRP279881,PRJNA612371,Danio rerio strain:TU Raw sequence reads,PRJNA612371,Whole Genome Sequencing,Hemorrhage stroke is a severe vascular disease of the brain with a high mortality rate in humans. Sodium tanshinone IIA sulfonate STS is a water soluble derivative of tanshinone IIA which is the main active ingredient of Salvia miltiorrhiza Bge known as Danshen in Chinese and has been approved as a commercial drug for treating cardiovascular disease by the China Food and Drug Administration. In our previous study we established a HMG COA inhibitor atorvastatin Ator induced zebrafish model of cerebral hemorrhage and found that STS dramatically decreased both the hemorrhage rate and hemorrhage area although the underlying mechanism was not fully elucidated. Therefore in the present study we conducted transcriptome analysis of the protective effect of STS against Ator induced cerebral hemorrhage in zebrafish using RNA Seq technology and further clarify its underlying molecular mechanisms on HIF 1 and its regulators i.e. the PI3K/Akt and MAPK signaling pathways were verified by real time PCR analysis and specific pharmacological inhibitors. We are also able to show that hemoglobin carbonic anhydrase Na+/H+ exchanger and HIF 1 genes might be potential biomarkers of Ator induced cerebral hemorrhage in zebrafish as well as pharmacological targets of STS. This study also provided evidence of bio markers involved in hemorrhage stroke and improved understanding of the effects of HMG COA inhibition on vascular permeability and cerebral hemorrhage.,,,,,Ctrl 3 zebrafish,,strain:TU|isolate:not collected|breed:not collected|cultivar:not collected|ecotype:not collected|age:2dpf|dev stage:not collected|sex:not applicable|tissue:head|geo loc name:China:Shanghai|sample type:model organism|replicate:replicate=biological replicate 6'|BioSampleModel:Model organism or animal,,,,,,,,,Ctrl 3 zebrafish,Ctrl 3 zebrafish,Ctrl 3 zebrafish,transcriptome,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,BGISEQ,BGISEQ-500,,SRP279881,,,Ctrl_3_1.fq.gz,fastq,1061227250.0,21224545.0,Ctrl 3 1.fq.gz,0:50,A:286099732;C:241244619;G:246876865;T:287006034;N:0,50,,,,286099732,241244619,246876865,287006034,0,SRX9064853,SRS7314026,SRA1120721,Shanghai University of Traditional Chinese Medicine|Longhua Hospital,Shanghai University of Traditional Chinese Medicine,1,0.94563,,0.10453,,0.70552,,0.46655,,50,,B,,usable mapping rate,bgi,bgi,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2020-09-03,Hatching,Embryo,Head,Nervous System 57272,SRR12577971,SRX9064852,SRS7314025,SRP279881,PRJNA612371,Danio rerio strain:TU Raw sequence reads,PRJNA612371,Whole Genome Sequencing,Hemorrhage stroke is a severe vascular disease of the brain with a high mortality rate in humans. Sodium tanshinone IIA sulfonate STS is a water soluble derivative of tanshinone IIA which is the main active ingredient of Salvia miltiorrhiza Bge known as Danshen in Chinese and has been approved as a commercial drug for treating cardiovascular disease by the China Food and Drug Administration. In our previous study we established a HMG COA inhibitor atorvastatin Ator induced zebrafish model of cerebral hemorrhage and found that STS dramatically decreased both the hemorrhage rate and hemorrhage area although the underlying mechanism was not fully elucidated. Therefore in the present study we conducted transcriptome analysis of the protective effect of STS against Ator induced cerebral hemorrhage in zebrafish using RNA Seq technology and further clarify its underlying molecular mechanisms on HIF 1 and its regulators i.e. the PI3K/Akt and MAPK signaling pathways were verified by real time PCR analysis and specific pharmacological inhibitors. We are also able to show that hemoglobin carbonic anhydrase Na+/H+ exchanger and HIF 1 genes might be potential biomarkers of Ator induced cerebral hemorrhage in zebrafish as well as pharmacological targets of STS. This study also provided evidence of bio markers involved in hemorrhage stroke and improved understanding of the effects of HMG COA inhibition on vascular permeability and cerebral hemorrhage.,,,,,Ctrl 2 zebrafish,,strain:TU|isolate:not collected|breed:not collected|cultivar:not collected|ecotype:not collected|age:2dpf|dev stage:not collected|sex:not applicable|tissue:head|geo loc name:China:Shanghai|sample type:model organism|replicate:replicate=biological replicate 5 prime|BioSampleModel:Model organism or animal,,,,,,,,,Ctrl 2 zebrafish,Ctrl 2 zebrafish,Ctrl 2 zebrafish,transcriptome,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,BGISEQ,BGISEQ-500,,SRP279881,,,Ctrl_2_1.fq.gz,fastq,1058116700.0,21162334.0,Ctrl 2 1.fq.gz,0:50,A:287223905;C:238707750;G:244987559;T:287197486;N:0,50,,,,287223905,238707750,244987559,287197486,0,SRX9064852,SRS7314025,SRA1120721,Shanghai University of Traditional Chinese Medicine|Longhua Hospital,Shanghai University of Traditional Chinese Medicine,1,0.94534,,0.11174,,0.70104,,0.47946,,50,,B,,usable mapping rate,bgi,bgi,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2020-09-03,Hatching,Embryo,Head,Nervous System 57273,SRR12577972,SRX9064851,SRS7314024,SRP279881,PRJNA612371,Danio rerio strain:TU Raw sequence reads,PRJNA612371,Whole Genome Sequencing,Hemorrhage stroke is a severe vascular disease of the brain with a high mortality rate in humans. Sodium tanshinone IIA sulfonate STS is a water soluble derivative of tanshinone IIA which is the main active ingredient of Salvia miltiorrhiza Bge known as Danshen in Chinese and has been approved as a commercial drug for treating cardiovascular disease by the China Food and Drug Administration. In our previous study we established a HMG COA inhibitor atorvastatin Ator induced zebrafish model of cerebral hemorrhage and found that STS dramatically decreased both the hemorrhage rate and hemorrhage area although the underlying mechanism was not fully elucidated. Therefore in the present study we conducted transcriptome analysis of the protective effect of STS against Ator induced cerebral hemorrhage in zebrafish using RNA Seq technology and further clarify its underlying molecular mechanisms on HIF 1 and its regulators i.e. the PI3K/Akt and MAPK signaling pathways were verified by real time PCR analysis and specific pharmacological inhibitors. We are also able to show that hemoglobin carbonic anhydrase Na+/H+ exchanger and HIF 1 genes might be potential biomarkers of Ator induced cerebral hemorrhage in zebrafish as well as pharmacological targets of STS. This study also provided evidence of bio markers involved in hemorrhage stroke and improved understanding of the effects of HMG COA inhibition on vascular permeability and cerebral hemorrhage.,,,,,Ctrl 1 zebrafish,,strain:TU|isolate:not collected|breed:not collected|cultivar:not collected|ecotype:not collected|age:2dpf|dev stage:not collected|sex:not applicable|tissue:head|geo loc name:China:Shanghai|sample type:model organism|replicate:replicate=biological replicate 4'|BioSampleModel:Model organism or animal,,,,,,,,,Ctrl 1 zebrafish,Ctrl 1 zebrafish,Ctrl 1 zebrafish,transcriptome,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,BGISEQ,BGISEQ-500,,SRP279881,,,Ctrl_1_1.fq.gz,fastq,1065919600.0,21318392.0,Ctrl 1 1.fq.gz,0:50,A:295920720;C:242146677;G:242962633;T:284889570;N:0,50,,,,295920720,242146677,242962633,284889570,0,SRX9064851,SRS7314024,SRA1120721,Shanghai University of Traditional Chinese Medicine|Longhua Hospital,Shanghai University of Traditional Chinese Medicine,1,0.94228,,0.15007,,0.68028,,0.46845,,50,,B,,usable mapping rate,bgi,bgi,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2020-09-03,Hatching,Embryo,Head,Nervous System 57274,SRR12577973,SRX9064850,SRS7314023,SRP279881,PRJNA612371,Danio rerio strain:TU Raw sequence reads,PRJNA612371,Whole Genome Sequencing,Hemorrhage stroke is a severe vascular disease of the brain with a high mortality rate in humans. Sodium tanshinone IIA sulfonate STS is a water soluble derivative of tanshinone IIA which is the main active ingredient of Salvia miltiorrhiza Bge known as Danshen in Chinese and has been approved as a commercial drug for treating cardiovascular disease by the China Food and Drug Administration. In our previous study we established a HMG COA inhibitor atorvastatin Ator induced zebrafish model of cerebral hemorrhage and found that STS dramatically decreased both the hemorrhage rate and hemorrhage area although the underlying mechanism was not fully elucidated. Therefore in the present study we conducted transcriptome analysis of the protective effect of STS against Ator induced cerebral hemorrhage in zebrafish using RNA Seq technology and further clarify its underlying molecular mechanisms on HIF 1 and its regulators i.e. the PI3K/Akt and MAPK signaling pathways were verified by real time PCR analysis and specific pharmacological inhibitors. We are also able to show that hemoglobin carbonic anhydrase Na+/H+ exchanger and HIF 1 genes might be potential biomarkers of Ator induced cerebral hemorrhage in zebrafish as well as pharmacological targets of STS. This study also provided evidence of bio markers involved in hemorrhage stroke and improved understanding of the effects of HMG COA inhibition on vascular permeability and cerebral hemorrhage.,,,,,Ator STS 3 zebrafish,,strain:TU|isolate:not collected|breed:not collected|cultivar:not collected|ecotype:not collected|age:2dpf|dev stage:not collected|sex:not applicable|tissue:head|geo loc name:China:Shanghai|sample type:model organism|replicate:replicate=biological replicate 3 prime|BioSampleModel:Model organism or animal,,,,,,,,,Ator STS 3 zebrafish,Ator STS 3 zebrafish,Ator STS 3 zebrafish,transcriptome,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,BGISEQ,BGISEQ-500,,SRP279881,,,Ator_STS_3_1.fq.gz,fastq,1059717350.0,21194347.0,Ator STS 3 1.fq.gz,0:50,A:287279590;C:239708340;G:245740313;T:286989107;N:0,50,,,,287279590,239708340,245740313,286989107,0,SRX9064850,SRS7314023,SRA1120721,Shanghai University of Traditional Chinese Medicine|Longhua Hospital,Shanghai University of Traditional Chinese Medicine,1,0.94345,,0.10458,,0.69686,,0.4755,,50,,B,,usable mapping rate,bgi,bgi,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2020-09-03,Hatching,Embryo,Head,Nervous System 57275,SRR12577974,SRX9064849,SRS7314022,SRP279881,PRJNA612371,Danio rerio strain:TU Raw sequence reads,PRJNA612371,Whole Genome Sequencing,Hemorrhage stroke is a severe vascular disease of the brain with a high mortality rate in humans. Sodium tanshinone IIA sulfonate STS is a water soluble derivative of tanshinone IIA which is the main active ingredient of Salvia miltiorrhiza Bge known as Danshen in Chinese and has been approved as a commercial drug for treating cardiovascular disease by the China Food and Drug Administration. In our previous study we established a HMG COA inhibitor atorvastatin Ator induced zebrafish model of cerebral hemorrhage and found that STS dramatically decreased both the hemorrhage rate and hemorrhage area although the underlying mechanism was not fully elucidated. Therefore in the present study we conducted transcriptome analysis of the protective effect of STS against Ator induced cerebral hemorrhage in zebrafish using RNA Seq technology and further clarify its underlying molecular mechanisms on HIF 1 and its regulators i.e. the PI3K/Akt and MAPK signaling pathways were verified by real time PCR analysis and specific pharmacological inhibitors. We are also able to show that hemoglobin carbonic anhydrase Na+/H+ exchanger and HIF 1 genes might be potential biomarkers of Ator induced cerebral hemorrhage in zebrafish as well as pharmacological targets of STS. This study also provided evidence of bio markers involved in hemorrhage stroke and improved understanding of the effects of HMG COA inhibition on vascular permeability and cerebral hemorrhage.,,,,,Ator STS 2 zebrafish,,strain:TU|isolate:not collected|breed:not collected|cultivar:not collected|ecotype:not collected|age:2dpf|dev stage:not collected|sex:not applicable|tissue:head|geo loc name:China:Shanghai|sample type:model organism|replicate:replicate=biological replicate 2'|BioSampleModel:Model organism or animal,,,,,,,,,Ator STS 2 zebrafish,Ator STS 2 zebrafish,Ator STS 2 zebrafish,transcriptome,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,BGISEQ,BGISEQ-500,,SRP279881,,,Ator_STS_2_1.fq.gz,fastq,1057950250.0,21159005.0,Ator STS 2 1.fq.gz,0:50,A:286256354;C:238832868;G:244078781;T:288782247;N:0,50,,,,286256354,238832868,244078781,288782247,0,SRX9064849,SRS7314022,SRA1120721,Shanghai University of Traditional Chinese Medicine|Longhua Hospital,Shanghai University of Traditional Chinese Medicine,1,0.94307,,0.10974,,0.69631,,0.4703,,50,,B,,usable mapping rate,bgi,bgi,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2020-09-03,Hatching,Embryo,Head,Nervous System 57276,SRR12577975,SRX9064848,SRS7314021,SRP279881,PRJNA612371,Danio rerio strain:TU Raw sequence reads,PRJNA612371,Whole Genome Sequencing,Hemorrhage stroke is a severe vascular disease of the brain with a high mortality rate in humans. Sodium tanshinone IIA sulfonate STS is a water soluble derivative of tanshinone IIA which is the main active ingredient of Salvia miltiorrhiza Bge known as Danshen in Chinese and has been approved as a commercial drug for treating cardiovascular disease by the China Food and Drug Administration. In our previous study we established a HMG COA inhibitor atorvastatin Ator induced zebrafish model of cerebral hemorrhage and found that STS dramatically decreased both the hemorrhage rate and hemorrhage area although the underlying mechanism was not fully elucidated. Therefore in the present study we conducted transcriptome analysis of the protective effect of STS against Ator induced cerebral hemorrhage in zebrafish using RNA Seq technology and further clarify its underlying molecular mechanisms on HIF 1 and its regulators i.e. the PI3K/Akt and MAPK signaling pathways were verified by real time PCR analysis and specific pharmacological inhibitors. We are also able to show that hemoglobin carbonic anhydrase Na+/H+ exchanger and HIF 1 genes might be potential biomarkers of Ator induced cerebral hemorrhage in zebrafish as well as pharmacological targets of STS. This study also provided evidence of bio markers involved in hemorrhage stroke and improved understanding of the effects of HMG COA inhibition on vascular permeability and cerebral hemorrhage.,,,,,Ator STS 1 zebrafish,,strain:TU|isolate:not collected|breed:not collected|cultivar:not collected|ecotype:not collected|age:2dpf|dev stage:not collected|sex:not applicable|tissue:head|geo loc name:China:Shanghai|sample type:model organism|replicate:replicate=biological replicate 1'|BioSampleModel:Model organism or animal,,,,,,,,,Ator STS 1 zebrafish,Ator STS 1 zebrafish,Ator STS 1 zebrafish,transcriptome,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,BGISEQ,BGISEQ-500,,SRP279881,,,Ator_STS_1_1.fq.gz,fastq,1070136700.0,21402734.0,Ator STS 1 1.fq.gz,0:50,A:297601042;C:243837062;G:243583907;T:285114689;N:0,50,,,,297601042,243837062,243583907,285114689,0,SRX9064848,SRS7314021,SRA1120721,Shanghai University of Traditional Chinese Medicine|Longhua Hospital,Shanghai University of Traditional Chinese Medicine,1,0.94665,,0.12219,,0.67953,,0.46393,,50,,B,,usable mapping rate,bgi,bgi,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2020-09-03,Hatching,Embryo,Head,Nervous System 57277,SRR12577976,SRX9064847,SRS7314020,SRP279881,PRJNA612371,Danio rerio strain:TU Raw sequence reads,PRJNA612371,Whole Genome Sequencing,Hemorrhage stroke is a severe vascular disease of the brain with a high mortality rate in humans. Sodium tanshinone IIA sulfonate STS is a water soluble derivative of tanshinone IIA which is the main active ingredient of Salvia miltiorrhiza Bge known as Danshen in Chinese and has been approved as a commercial drug for treating cardiovascular disease by the China Food and Drug Administration. In our previous study we established a HMG COA inhibitor atorvastatin Ator induced zebrafish model of cerebral hemorrhage and found that STS dramatically decreased both the hemorrhage rate and hemorrhage area although the underlying mechanism was not fully elucidated. Therefore in the present study we conducted transcriptome analysis of the protective effect of STS against Ator induced cerebral hemorrhage in zebrafish using RNA Seq technology and further clarify its underlying molecular mechanisms on HIF 1 and its regulators i.e. the PI3K/Akt and MAPK signaling pathways were verified by real time PCR analysis and specific pharmacological inhibitors. We are also able to show that hemoglobin carbonic anhydrase Na+/H+ exchanger and HIF 1 genes might be potential biomarkers of Ator induced cerebral hemorrhage in zebrafish as well as pharmacological targets of STS. This study also provided evidence of bio markers involved in hemorrhage stroke and improved understanding of the effects of HMG COA inhibition on vascular permeability and cerebral hemorrhage.,,,,,Ator 3 zebrafish,,strain:TU|isolate:not collected|breed:not collected|cultivar:not collected|ecotype:not collected|age:2dpf|dev stage:not collected|sex:not applicable|tissue:head|geo loc name:China:Shanghai|sample type:model organism|replicate:replicate=biological replicate 3 prime|BioSampleModel:Model organism or animal,,,,,,,,,Ator 3 zebrafish,Ator 3 zebrafish,Ator 3 zebrafish,transcriptome,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,BGISEQ,BGISEQ-500,,SRP279881,,,Ator_3_1.fq.gz,fastq,1058031900.0,21160638.0,Ator 3 1.fq.gz,0:50,A:285399527;C:239993172;G:245571467;T:287067734;N:0,50,,,,285399527,239993172,245571467,287067734,0,SRX9064847,SRS7314020,SRA1120721,Shanghai University of Traditional Chinese Medicine|Longhua Hospital,Shanghai University of Traditional Chinese Medicine,1,0.94536,,0.11052,,0.6957,,0.48195,,50,,B,,usable mapping rate,bgi,bgi,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2020-09-03,Hatching,Embryo,Head,Nervous System 57278,SRR12577977,SRX9064846,SRS7314019,SRP279881,PRJNA612371,Danio rerio strain:TU Raw sequence reads,PRJNA612371,Whole Genome Sequencing,Hemorrhage stroke is a severe vascular disease of the brain with a high mortality rate in humans. Sodium tanshinone IIA sulfonate STS is a water soluble derivative of tanshinone IIA which is the main active ingredient of Salvia miltiorrhiza Bge known as Danshen in Chinese and has been approved as a commercial drug for treating cardiovascular disease by the China Food and Drug Administration. In our previous study we established a HMG COA inhibitor atorvastatin Ator induced zebrafish model of cerebral hemorrhage and found that STS dramatically decreased both the hemorrhage rate and hemorrhage area although the underlying mechanism was not fully elucidated. Therefore in the present study we conducted transcriptome analysis of the protective effect of STS against Ator induced cerebral hemorrhage in zebrafish using RNA Seq technology and further clarify its underlying molecular mechanisms on HIF 1 and its regulators i.e. the PI3K/Akt and MAPK signaling pathways were verified by real time PCR analysis and specific pharmacological inhibitors. We are also able to show that hemoglobin carbonic anhydrase Na+/H+ exchanger and HIF 1 genes might be potential biomarkers of Ator induced cerebral hemorrhage in zebrafish as well as pharmacological targets of STS. This study also provided evidence of bio markers involved in hemorrhage stroke and improved understanding of the effects of HMG COA inhibition on vascular permeability and cerebral hemorrhage.,,,,,Ator 2 zebrafish,,strain:TU|isolate:not collected|breed:not collected|cultivar:not collected|ecotype:not collected|age:2dpf|dev stage:not collected|sex:not applicable|tissue:head|geo loc name:China:Shanghai|sample type:model organism|replicate:replicate=biological replicate 2'|BioSampleModel:Model organism or animal,,,,,,,,,Ator 2 zebrafish,Ator 2 zebrafish,Ator 2 zebrafish,transcriptome,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,BGISEQ,BGISEQ-500,,SRP279881,,,Ator_2_1.fq.gz,fastq,1059618400.0,21192368.0,Ator 2 1.fq.gz,0:50,A:283429136;C:243023053;G:248904818;T:284261393;N:0,50,,,,283429136,243023053,248904818,284261393,0,SRX9064846,SRS7314019,SRA1120721,Shanghai University of Traditional Chinese Medicine|Longhua Hospital,Shanghai University of Traditional Chinese Medicine,1,0.94743,,0.09493,,0.70218,,0.475,,50,,B,,usable mapping rate,bgi,bgi,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2020-09-03,Hatching,Embryo,Head,Nervous System 57279,SRR12577978,SRX9064845,SRS7314018,SRP279881,PRJNA612371,Danio rerio strain:TU Raw sequence reads,PRJNA612371,Whole Genome Sequencing,Hemorrhage stroke is a severe vascular disease of the brain with a high mortality rate in humans. Sodium tanshinone IIA sulfonate STS is a water soluble derivative of tanshinone IIA which is the main active ingredient of Salvia miltiorrhiza Bge known as Danshen in Chinese and has been approved as a commercial drug for treating cardiovascular disease by the China Food and Drug Administration. In our previous study we established a HMG COA inhibitor atorvastatin Ator induced zebrafish model of cerebral hemorrhage and found that STS dramatically decreased both the hemorrhage rate and hemorrhage area although the underlying mechanism was not fully elucidated. Therefore in the present study we conducted transcriptome analysis of the protective effect of STS against Ator induced cerebral hemorrhage in zebrafish using RNA Seq technology and further clarify its underlying molecular mechanisms on HIF 1 and its regulators i.e. the PI3K/Akt and MAPK signaling pathways were verified by real time PCR analysis and specific pharmacological inhibitors. We are also able to show that hemoglobin carbonic anhydrase Na+/H+ exchanger and HIF 1 genes might be potential biomarkers of Ator induced cerebral hemorrhage in zebrafish as well as pharmacological targets of STS. This study also provided evidence of bio markers involved in hemorrhage stroke and improved understanding of the effects of HMG COA inhibition on vascular permeability and cerebral hemorrhage.,,,,,Ator 1 zebrafish,,strain:TU|isolate:not collected|breed:not collected|cultivar:not collected|ecotype:not collected|age:2dpf|dev stage:not collected|sex:not applicable|tissue:head|geo loc name:China:Shanghai|sample type:model organism|replicate:replicate=biological replicate 1'|BioSampleModel:Model organism or animal,,,,,,,,,Ator 1 zebrafish,Ator 1 zebrafish,Ator 1 zebrafish,transcriptome,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,BGISEQ,BGISEQ-500,,SRP279881,,,Ator_1_1.fq.gz,fastq,1075695950.0,21513919.0,Ator 1 1.fq.gz,0:50,A:297768036;C:244470267;G:243768925;T:289688722;N:0,50,,,,297768036,244470267,243768925,289688722,0,SRX9064845,SRS7314018,SRA1120721,Shanghai University of Traditional Chinese Medicine|Longhua Hospital,Shanghai University of Traditional Chinese Medicine,1,0.94468,,0.13183,,0.68363,,0.46288,,50,,B,,usable mapping rate,bgi,bgi,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2020-09-03,Hatching,Embryo,Head,Nervous System 60104,SRR12142045,SRX8663215,SRS6944340,SRP269853,PRJNA643885,performance test of DeLTa Seq,PRJNA643885,Other,This data set were used for development and performance evaluation of Direct lysate targeted RNA Seq DeLTa Seq,,,RNA Seq of lysate for FigS2,,zebrafish lysate biological replicate 4,,strain:AB|age:2 days|sex:hermaphrodite|tissue:whole|sample type:lysate|fig:S2|replicate:biological replicate 4|BioSampleModel:Model organism or animal,,,,,,,,,DeLTa Seq,Dre 4,Dre 4,cDNA was synthesized with the lysate. Non targeted RNA Seq were conducted according to Lasy Seq ver. 1.1 protocol18 https://sites.google.com/view/lasy seq/.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina HiSeq 2500,,SRP269853,,,DreSceMix_g004_1.fastq.gz,fastq,509713380.0,9994380.0,DreSceMix g004 1.fastq.gz,0:51,A:251366594;C:61585710;G:62159129;T:134578953;N:22994,51,,,,251366594,61585710,62159129,134578953,22994,SRX8663215,SRS6944340,SRA1094353,Ryukoku university|Fauculity of Agriculture,Ryukoku university,1,0.67392,,0.54102,,0.86476,,0.37091,,51,,B,,usable mapping rate,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,Japan,2020-07-03,Hatching,Embryo,Undetermined,Embryo Imprecise 60105,SRR12141709,SRX8663075,SRS6944200,SRP269853,PRJNA643885,performance test of DeLTa Seq,PRJNA643885,Other,This data set were used for development and performance evaluation of Direct lysate targeted RNA Seq DeLTa Seq,,,RNA Seq of lysate for FigS2,,zebrafish lysate biological replicate 3,,strain:AB|age:2 days|sex:hermaphrodite|tissue:whole|sample type:lysate|fig:S2|replicate:biological replicate 3|BioSampleModel:Model organism or animal,,,,,,,,,DeLTa Seq,Dre 3,Dre 3,cDNA was synthesized with the lysate. Non targeted RNA Seq were conducted according to Lasy Seq ver. 1.1 protocol18 https://sites.google.com/view/lasy seq/.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina HiSeq 2500,,SRP269853,,,DreSceMix_g003_1.fastq.gz,fastq,499717482.0,9798382.0,DreSceMix g003 1.fastq.gz,0:51,A:263221073;C:56114768;G:56547079;T:123812019;N:22543,51,,,,263221073,56114768,56547079,123812019,22543,SRX8663075,SRS6944200,SRA1094353,Ryukoku university|Fauculity of Agriculture,Ryukoku university,1,0.63258,,0.48288,,0.86819,,0.35874,,51,,B,,usable mapping rate,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,Japan,2020-07-03,Hatching,Embryo,Undetermined,Embryo Imprecise 60106,SRR12141808,SRX8662976,SRS6944101,SRP269853,PRJNA643885,performance test of DeLTa Seq,PRJNA643885,Other,This data set were used for development and performance evaluation of Direct lysate targeted RNA Seq DeLTa Seq,,,RNA Seq of purified RNA from lysate for Fig.S2,,zebrafish purifiedRNA biological replicate 6,,strain:AB|age:2 days|sex:hermaphrodite|tissue:whole|sample type:purified from lysate|fig:S2|replicate:biological replicate 6|BioSampleModel:Model organism or animal,,,,,,,,,DeLTa Seq,Dre 12,Dre 12,cDNA was synthesized with the purified RNA. Non targeted RNA Seq were conducted according to Lasy Seq ver. 1.1 protocol18 https://sites.google.com/view/lasy seq/.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina HiSeq 2500,,SRP269853,,,DreSceMix_g014_1.fastq.gz,fastq,421063599.0,8256149.0,DreSceMix g014 1.fastq.gz,0:51,A:207118237;C:53600213;G:54041718;T:106284709;N:18722,51,,,,207118237,53600213,54041718,106284709,18722,SRX8662976,SRS6944101,SRA1094353,Ryukoku university|Fauculity of Agriculture,Ryukoku university,1,0.47999,,0.19308,,0.85977,,0.46733,,51,,B,,usable mapping rate,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,Japan,2020-07-03,Hatching,Embryo,Undetermined,Embryo Imprecise 60107,SRR12141828,SRX8662956,SRS6944081,SRP269853,PRJNA643885,performance test of DeLTa Seq,PRJNA643885,Other,This data set were used for development and performance evaluation of Direct lysate targeted RNA Seq DeLTa Seq,,,RNA Seq of purified RNA from lysate for Fig.S2,,zebrafish purifiedRNA biological replicate 4,,strain:AB|age:2 days|sex:hermaphrodite|tissue:whole|sample type:purified from lysate|fig:S2|replicate:biological replicate 4|BioSampleModel:Model organism or animal,,,,,,,,,DeLTa Seq,Dre 10,Dre 10,cDNA was synthesized with the purified RNA. Non targeted RNA Seq were conducted according to Lasy Seq ver. 1.1 protocol18 https://sites.google.com/view/lasy seq/.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina HiSeq 2500,,SRP269853,,,DreSceMix_g012_1.fastq.gz,fastq,626464773.0,12283623.0,DreSceMix g012 1.fastq.gz,0:51,A:263307070;C:96744908;G:98635228;T:167749896;N:27671,51,,,,263307070,96744908,98635228,167749896,27671,SRX8662956,SRS6944081,SRA1094353,Ryukoku university|Fauculity of Agriculture,Ryukoku university,1,0.50608,,0.14369,,0.83422,,0.45691,,51,,B,,usable mapping rate,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,Japan,2020-07-03,Hatching,Embryo,Undetermined,Embryo Imprecise 60108,SRR12141839,SRX8662945,SRS6944070,SRP269853,PRJNA643885,performance test of DeLTa Seq,PRJNA643885,Other,This data set were used for development and performance evaluation of Direct lysate targeted RNA Seq DeLTa Seq,,,RNA Seq of purified RNA from lysate for Fig.S2,,zebrafish purifiedRNA biological replicate 3,,strain:AB|age:2 days|sex:hermaphrodite|tissue:whole|sample type:purified from lysate|fig:S2|replicate:biological replicate 3|BioSampleModel:Model organism or animal,,,,,,,,,DeLTa Seq,Dre 9,Dre 9,cDNA was synthesized with the purified RNA. Non targeted RNA Seq were conducted according to Lasy Seq ver. 1.1 protocol18 https://sites.google.com/view/lasy seq/.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina HiSeq 2500,,SRP269853,,,DreSceMix_g011_1.fastq.gz,fastq,436381296.0,8556496.0,DreSceMix g011 1.fastq.gz,0:51,A:205579619;C:58008903;G:59021026;T:113752218;N:19530,51,,,,205579619,58008903,59021026,113752218,19530,SRX8662945,SRS6944070,SRA1094353,Ryukoku university|Fauculity of Agriculture,Ryukoku university,1,0.46615,,0.18281,,0.84778,,0.44592,,51,,B,,usable mapping rate,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,Japan,2020-07-03,Hatching,Embryo,Undetermined,Embryo Imprecise 60109,SRR12141850,SRX8662934,SRS6944059,SRP269853,PRJNA643885,performance test of DeLTa Seq,PRJNA643885,Other,This data set were used for development and performance evaluation of Direct lysate targeted RNA Seq DeLTa Seq,,,RNA Seq of purified RNA from lysate for Fig.S2,,zebrafish purifiedRNA biological replicate 2,,strain:AB|age:2 days|sex:hermaphrodite|tissue:whole|sample type:purified from lysate|fig:S2|replicate:biological replicate 2|BioSampleModel:Model organism or animal,,,,,,,,,DeLTa Seq,Dre 8,Dre 8,cDNA was synthesized with the purified RNA. Non targeted RNA Seq were conducted according to Lasy Seq ver. 1.1 protocol18 https://sites.google.com/view/lasy seq/.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina HiSeq 2500,,SRP269853,,,DreSceMix_g010_1.fastq.gz,fastq,870727437.0,17073087.0,DreSceMix g010 1.fastq.gz,0:51,A:343772776;C:142428987;G:145570260;T:238917135;N:38279,51,,,,343772776,142428987,145570260,238917135,38279,SRX8662934,SRS6944059,SRA1094353,Ryukoku university|Fauculity of Agriculture,Ryukoku university,1,0.52883,,0.1235,,0.82256,,0.45498,,51,,B,,usable mapping rate,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,Japan,2020-07-03,Hatching,Embryo,Undetermined,Embryo Imprecise 60110,SRR12141861,SRX8662923,SRS6944047,SRP269853,PRJNA643885,performance test of DeLTa Seq,PRJNA643885,Other,This data set were used for development and performance evaluation of Direct lysate targeted RNA Seq DeLTa Seq,,,RNA Seq of purified RNA from lysate for Fig.S2,,zebrafish purifiedRNA biological replicate 1,,strain:AB|age:2 days|sex:hermaphrodite|tissue:whole|sample type:purified from lysate|fig:S2|replicate:biological replicate 1|BioSampleModel:Model organism or animal,,,,,,,,,DeLTa Seq,Dre 7,Dre 7,cDNA was synthesized with the purified RNA. Non targeted RNA Seq were conducted according to Lasy Seq ver. 1.1 protocol18 https://sites.google.com/view/lasy seq/.,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,Illumina HiSeq 2500,,SRP269853,,,DreSceMix_g009_1.fastq.gz,fastq,1875928206.0,36782906.0,DreSceMix g009 1.fastq.gz,0:51,A:684015713;C:329272255;G:335557540;T:526999083;N:83615,51,,,,684015713,329272255,335557540,526999083,83615,SRX8662923,SRS6944047,SRA1094353,Ryukoku university|Fauculity of Agriculture,Ryukoku university,1,0.58553,,0.11315,,0.8029,,0.4678,,51,,B,,usable mapping rate,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,Japan,2020-07-03,Hatching,Embryo,Undetermined,Embryo Imprecise